TRUMAB 150 MG is a targeted biological therapy containing Trastuzumab, a monoclonal antibody specifically engineered to treat HER2-positive cancers. Manufactured by Glenmark Pharmaceuticals, it is a trusted biosimilar used in the treatment of HER2-positive breast cancer and metastatic gastric (stomach) cancer. Trumab works by binding to the Human Epidermal Growth Factor Receptor 2 (HER2) proteins found on the surface of specific cancer cells. By blocking these receptors, it inhibits the growth signals that cause tumors to spread and alerts the body’s immune system to target and destroy the malignant cells. The 150 mg vial provides flexible dosing options for individualized clinical protocols.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.